Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Olshansky

Showing results (291-300 of 334) with videos related to

Pageof 34
Sort By:
Journal of the American Heart Association|February 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-ITBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 3, 2020
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final resultsBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
Thrombosis and Haemostasis|December 7, 2017
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, et al.
Heart Rhythm|November 4, 2018
Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports RegistryBrian Olshansky, Gourg Atteya, David Cannom, et al.
Circulation. Arrhythmia and Electrophysiology|March 16, 2021
Implantable Cardioverter Defibrillator Lead Survival in Athletic PatientsMark S Link, Renee M Sullivan, Brian Olshansky, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 3, 2017
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|October 11, 2007
Sport and arrhythmias: summary of an international symposiumFranco Giada, Serge S Barold, Alessandro Biffi, et al.
Circulation|November 12, 2019
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United StatesDeepak L Bhatt, Michael Miller, Eliot A Brinton, et al.
Heart Rhythm|March 14, 2017
2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, Win-Kuang Shen, Robert S Sheldon, et al.
Circulation|March 11, 2017
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyWin-Kuang Shen, Robert S Sheldon, David G Benditt, et al.
Pageof 34

Showing results (291-300 of 334) with videos related to

Sort By:
Pageof 34
Journal of the American Heart Association|February 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-ITBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 3, 2020
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final resultsBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
Thrombosis and Haemostasis|December 7, 2017
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, et al.
Heart Rhythm|November 4, 2018
Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports RegistryBrian Olshansky, Gourg Atteya, David Cannom, et al.
Circulation. Arrhythmia and Electrophysiology|March 16, 2021
Implantable Cardioverter Defibrillator Lead Survival in Athletic PatientsMark S Link, Renee M Sullivan, Brian Olshansky, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 3, 2017
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|October 11, 2007
Sport and arrhythmias: summary of an international symposiumFranco Giada, Serge S Barold, Alessandro Biffi, et al.
Circulation|November 12, 2019
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United StatesDeepak L Bhatt, Michael Miller, Eliot A Brinton, et al.
Heart Rhythm|March 14, 2017
2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, Win-Kuang Shen, Robert S Sheldon, et al.
Circulation|March 11, 2017
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyWin-Kuang Shen, Robert S Sheldon, David G Benditt, et al.
Pageof 34